Three beginner peptides for TikTok: what the science says

What did @realnickcalabrese actually say?

Nick pitched three peptides as the best starting point for beginners: retatrutide ("reder") for appetite suppression, BPC-157 plus TB-500 (the "Wolverine combo") for injury healing, and melanotan II (MT2) for tanning. His selling points were simple: retatrutide is fool-proof because "your appetite goes away after like the first week," the BPC/TB-500 stack lets you "heal injuries faster," and MT2 lets you be "a 10 in the winter." He also casually mentioned he still has a tan from a single session of something (presumably a tanning bed or MT2 use) months ago. None of this came with dosing caveats, safety warnings, or any acknowledgment that most of these compounds are either unapproved, unregulated, or carry real risks.

Does the science back this up?

Partially, but with serious caveats depending on which peptide you're looking at. The three compounds sit in very different places on the evidence spectrum, and lumping them together as a beginner-friendly starter pack is a stretch at best.

Retatrutide is the most legitimately studied of the three. It is a triple GIP/GLP-1/glucagon receptor agonist currently in Phase 2 clinical trials. Jastreboff et al. (2023, NEJM) reported mean body weight reduction of up to 24.2% over 48 weeks in adults with obesity, which is a genuinely impressive signal. The appetite suppression Nick describes is a real, documented effect. But retatrutide is not approved by the FDA. It is being investigated as a prescription drug, not a supplement people self-administer at home.

BPC-157 and TB-500 are a different story. BPC-157 has shown regenerative effects in rodent models (Chang et al., 2011, Journal of Physiology-Paris), but human clinical trial data is essentially nonexistent. TB-500 (a synthetic fragment of thymosin beta-4) has similar animal data and similarly thin human evidence. Calling this the "Wolverine combo" is fun branding, not pharmacology.

MT2 (melanotan II) is arguably the most problematic recommendation here. It is not approved anywhere for human use. It stimulates melanogenesis and can cause nausea, spontaneous erections, and changes in existing moles. The European Medicines Agency has warned against its use. Long-term safety data is absent.

What did they get wrong (or right)?

He got one thing right: retatrutide does suppress appetite in a way that is hard to miss. That part is grounded in actual trial data. The "you will know it's working" framing is fair for that mechanism.

But several things are wrong or missing. First, framing these as beginner peptides ignores that none of them are FDA-approved for the uses he describes, and that sourcing them outside a regulated clinical context means quality control is anyone's guess. Research-grade peptide suppliers are not pharmaceutical manufacturers. Second, the BPC-157 and TB-500 healing claims, while interesting in animal models, have not been validated in controlled human trials. Presenting them as a reliable injury fix is getting ahead of the evidence. Third, MT2 as a cosmetic tanning agent is a genuinely risky recommendation. Nick says he's "vain" like it's a harmless joke, but MT2 has been linked to melanoma-related concerns and significant side effects. Recommending it to a 15,000-person audience without a single safety note is irresponsible.

What should you actually know?

These three peptides are not interchangeable, and they are not equivalently safe or studied. If you are drawn to retatrutide for weight loss, that conversation belongs with a licensed clinician, not a TikTok comment section. Legitimate telehealth providers can evaluate whether GLP-1-class therapies are appropriate for you based on your actual health history.

BPC-157 and TB-500 are genuinely interesting research compounds, and some practitioners are beginning to use them in supervised settings. But "heal injuries faster" is not a proven clinical outcome in humans yet. Enthusiasm is not evidence.

MT2 should not be on any beginner list. The FDA has not approved it. The EMA has warned against it. The tanning effect Nick shows off carries real unknowns around melanocyte stimulation and long-term skin risk. Looking tan in February is not worth an uncharacterized risk profile.

If you are curious about peptide therapy, the starting point is a clinician who can order labs, review your history, and prescribe through a licensed compounding pharmacy with quality standards. Self-sourcing unregulated peptides because someone on TikTok looked good is not a strategy.